Company file

Identity

Poietis

Poietis is a bioprinting company specializing in the development of new biomanufacturing solutions, based on Laser-Assisted Bioprinting, for human tissues. Poietis mission is to provide clinicians and patients with tissue engineering therapies thanks to its innovative, proprietary Next-Generation Bioprinting platform (NGB).

Poietis' multimodal NGB platform is declined in two versions: a first one already commercialized for in vitro tissue engineering research (NGB-R), and a clinical version (NGB-C) for the production of implantable bioprinted tissues. This multi-modal, automated biomanufacturing platform enables researchers to achieve superior tissue through high resolution, and enables the fabrication of complex tissues with repeatability and reproducibility. Poietis has a collaboration with the Assistance Publique - Hôpitaux de Marseille (AP-HM) to prepare the first clinical trial of a bioprinted skin, and will be able to provide access to its NGB platform for other advanced therapy medicines in development.